Tango Therapeutics, Inc. (TNGX)
22.76
+0.44
(+1.97%)
USD |
NASDAQ |
Sep 03, 16:00
22.66
-0.10
(-0.44%)
After-Hours: 17:41
Tango Therapeutics Net Income (Annual) : -101.59M for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -101.59M |
| December 31, 2024 | -130.30M |
| December 31, 2023 | -101.74M |
| Date | Value |
|---|---|
| December 31, 2022 | -108.18M |
| December 31, 2021 | -58.24M |
| December 31, 2020 | -51.97M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Revolution Medicines, Inc. | -1.131B |
| Erasca, Inc. | -124.55M |
| NovelStem International Corp. | 2.380M |
| Brainstorm Cell Therapeutics, Inc. | -10.31M |
| Summit Therapeutics, Inc. | -1.080B |